Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
This study has been completed.
Study NCT00005847 Information provided by National Cancer Institute (NCI)
First Received: June 2, 2000 Last Updated: August 1, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Prostate Cancer
Additional conditions recognized in this trial
Prostatic Neoplasms
More general conditions related to this trial
Genital Diseases, Male
Genital Neoplasms, Male
Neoplasms
Neoplasms by Site
Prostatic Diseases
Urogenital Neoplasms
Interventions listed in this trial
recombinant interferon alfa
estramustine phosphate sodium
isotretinoin
mitoxantrone hydrochloride
paclitaxel
vinorelbine ditartrate
Additional drug interventions recognized in this trial
Estramustine
Interferon Alfa-2a
Interferon Type I, Recombinant
Interferon-alpha
Interferons
Mitoxantrone
Vinblastine
Vinorelbine
More general drug interventions related to this trial
Alkylating Agents
Analgesics
Angiogenesis Inhibitors
Angiogenesis Modulating Agents
Anti-Infective Agents
Antimitotic Agents
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Antineoplastic Agents, Hormonal
Antineoplastic Agents, Phytogenic
Antiviral Agents
Central Nervous System Agents
Dermatologic Agents
Growth Inhibitors
Growth Substances
Immunologic Factors
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Tubulin Modulators
Sponsors listed in this trial
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)
Back to top of Main Content
